Phase 1
๐ Investigational Drug / Biologic
NCT04804891
Using T-Cell Alloreactivity and Chimerism to Guide Immunosuppression Minimization in Intestinal Transplantation
๐ Columbia University Irving Medical Center/NYP โ New York, New York
View Study & Screener โ